A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
OUR BUSINESS KORU Medical develops, manufactures and commercializes innovative and patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market as governed by the United States Food and Drug Administration (the “FDA”) quality and regulatory system and international standards for quality system management. Our focus is primarily concentrated on our mechanical infusion products, the FREEDOM Infusion Systems (which we refer to as the “FREEDOM System” when used with one or more accessories), which include the FREEDOM60® Syringe Driver, the FreedomEdge® Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets™ and Precision Flow Rate Tubing™. Our revenues are derived from three business sources: (i) domestic core (which consists of US and Canada), (ii) international core, and (iii) novel therapies.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 39M | 34M | 29M | 28M | 23M | 24M |
| Net Income | -3.7M | -6.1M | -14M | -8.7M | -4.6M | -1.2M |
| EPS | $0.02 | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 |
| Free Cash Flow | -174K | -1.6M | -5.7M | -8.2M | -4.7M | -1.7M |
| ROIC | -2931.2% | -35.7% | -66.5% | -27.3% | -12.5% | -3.4% |
| Gross Margin | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% |
| Debt/Equity | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.00 |
| Dividends/Share | $0.00 | - | - | $0.00 | - | - |
| Operating Income | -4.0M | -6.4M | -10M | -11M | -7.0M | -1.3M |
| Operating Margin | -10.3% | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% |
| ROE | -22.5% | -32.6% | -67.5% | -27.6% | -12.5% | -3.4% |
| Shares Outstanding | 46M | 47M | 46M | 46M | 46M | 40M |
KORU Medical Systems, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 59.5%. At current prices, the estimated annualized return to fair value is -29.7%.
KORU Medical Systems, Inc. (KRMD) has a 5-year average return on invested capital (ROIC) of -29.1%. This is below average and may indicate limited pricing power.
KORU Medical Systems, Inc. (KRMD) has a market capitalization of $199M. It is classified as a small-cap stock.
KORU Medical Systems, Inc. (KRMD) does not currently pay a regular dividend.
KORU Medical Systems, Inc. (KRMD) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
KORU Medical Systems, Inc. (KRMD) reported annual revenue of $34 million in its most recent fiscal year, based on SEC EDGAR filings.
KORU Medical Systems, Inc. (KRMD) has a net profit margin of -18.0%. The company is currently unprofitable.
KORU Medical Systems, Inc. (KRMD) generated $-2 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
KORU Medical Systems, Inc. (KRMD) has a debt-to-equity ratio of 0.04. This indicates a conservatively financed balance sheet.
KORU Medical Systems, Inc. (KRMD) reported earnings per share (EPS) of $-0.13 in its most recent fiscal year.
KORU Medical Systems, Inc. (KRMD) has a return on equity (ROE) of -32.6%. A negative ROE may indicate losses or negative equity.
KORU Medical Systems, Inc. (KRMD) has a 5-year average gross margin of 59.5%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 14 years of financial data for KORU Medical Systems, Inc. (KRMD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
KORU Medical Systems, Inc. (KRMD) has a book value per share of $0.36, based on its most recent annual SEC filing.